SPONSORED ARTICLE
By Elric Langton | 9 February 2022
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, provides a strategic and commercial update.Β
I have often discussed the Company strategy and various revenues streams associated with its B2B, B2c, and now direct β¦